Innospec reported a strong second quarter with a 32% increase in revenues and a 25% increase in operating income compared to the same period last year. The company's performance was driven by volume growth and price/mix improvements across all businesses. GAAP EPS was $1.29, and adjusted non-GAAP EPS was $1.58.
Revenues increased by 32% compared to the prior year, reaching $467.6 million.
Operating income grew by 25% year-over-year, driven by volume growth and price/mix improvements.
GAAP EPS was reported at $1.29, while adjusted non-GAAP EPS reached $1.58.
Strong demand for personal care chemistries drove margin improvement in Performance Chemicals.
Innospec expects demand to remain strong in the majority of its businesses entering the second half of 2022. The company believes its businesses are well-positioned to navigate near-term headwinds, including higher interest rates, persistent inflation, and European energy concerns. Oilfield Services continues to have significant growth potential with the target of returning to pre-COVID operating income levels over the medium term.
Visualization of income flow from segment revenue to net income